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INTRODUCTION
Recently, staphylococcal superantigens (SsAgs) have been
tentatively implicated in the pathogenesis of atopic dermati-
tis (AD). Lyden et al. (1) reported that over 90% of the skin
of AD patients was colonized with Staphylococcus aureus, and
over half of the S. aureus strains isolated from AD skin exhibit-
ed the secretion of superantigenic toxins, including staphy-
lococcal enterotoxins A and B (SEA, SEB), and toxic shock
syndrome toxin-1 (TSST-1) (2, 3). It was also found that com-
bined AD treatment involving both antibiotics and corticos-
teroids is more effective than corticosteroid therapy alone, also
suggesting that S. aureus plays an important role in AD (4). 
Dermatitis has also been experimentally induced via the
application of SEB to normal skin or normal-looking skin in
AD patients (5). When SsAgs were added to cultured ker-
atinocytes (KCs), TNF- secretion was observed to increase
(6). The addition of SsAg to organ-cultured human skin re-
sulted in increases in ICAM-1 or TNF- expression (7). These
results demonstrate that SsAgs may exert a direct influence
on KCs. However, no difference was determined to exist bet-
ween AD patients and normal controls with regard to the
ability to produce IgG antibody against SsAgs, or its preva-
lence (8). This indicates that the immunological abnormali-
ty against SsAgs observed in AD patients may be couched in
the KCs themselves. KCs cultured from AD patients have
been observed to generate increased amounts of GM-CSF and
other proinflammatory cytokines (TNF- and IL-1 ), as the
result of exposure to phorbol myristate acetate (9, 10). This
dysregulated cytokine production in KCs further suggests
that the keratinocytes themselves may have intrinsic defects
in cases of AD.
SsAgs isolated from AD patients have been shown to exert
direct pro-inflammatory effects on KCs via TNF- release,
and these effects may be relevant to the induction and persis-
tence of AD lesions (6). In studies of psoriasis patients, it has
been reported that HLA-DR expression in KCs exacerbates
inflammatory skin responses to SsAgs (11). This indicates
that smaller quantities of SsAgs are required to trigger inflam-
mation in vivo in subjects in whom the KCs exhibit HLA-
DR expression. 
People are frequently exposed to SsAgs. This raises the obvi-
ous question as to why AD patients characteristically devel-
op lesions, especially on flexural areas which are exposed to
SsAgs. Therefore, our hypothesis was that lesional KCs from
AD may react differently to SsAgs than does nonlesional skin
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Role of Staphylococcal Superantigen in Atopic Dermatitis: Influence
on Keratinocytes
Staphylococcus aureus may perform an crucial function in atopic dermatitis (AD),
via the secretion of superantigens, including staphylococcal enterotoxins (SE) A or
B, and toxic shock syndrome toxin-1 (TSST-1). Dysregulated cytokine production
by keratinocytes (KCs) upon exposure to staphylococcal superantigens (SsAgs) may
be principally involved in the pathophysiology of AD. We hypothesized that lesion-
al KCs from AD may react differently to SsAgs compared to nonlesional skin or nor-
mal skin from nonatopics. We conducted a comparison of HLA-DR or CD1a expres-
sion in lesional skin as opposed to that in nonlesional or normal skin by immunohis-
tochemistry (IHC). We also compared, using ELISA, the levels of IL-1 , IL-1 , and
TNF- secreted by cultured KCs from lesional, nonlesional, and normal skin, after
the addition of SEA, SEB and TSST-1. IHC revealed that both HLA-DR and CD1a
expression increased significantly in the epidermis of lesional skin versus nonlesion-
al or normal skin in quite a similar manner. IL-1 , IL-1 , and TNF- secretion was
also significantly elevated in the cultured KCs from lesional skin after the addition of
SsAgs. Our results indicated that KCs from lesional skin appear to react differently
to SsAgs and increased proinflammatory cytokine production in response to SsAgs
may contribute to the pathogenesis of AD.
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or normal skin, due to the production of a greater quantity
of proinflammatory cytokines in the KCs. In order to evalu-
ate this hypothesis, we acquired 3 different skin samples from
lesional and nonlesional (normal looking) skin from AD pa-
tients, and normal skin from nonatopic controls. We then
conducted a comparison with regard to HLA-DR or CD1a
expression, and measured a variety of cytokine responses (IL-
1 , IL-1 , and TNF- ) to SsAgs in the cultured KCs of these
3 different skin samples. 
MATERIALS AND METHODS
Skin samples
We obtained 3 different types of skin samples; 1) lesional
skin, 2) nonlesional (normal looking) skin from 8 AD patients
(8 males, age range 22-29 yr), and 3) normal skin from the
inner arms of nonatopic controls. We obtained 2 matched
skin samples from each patient: lesional skin from the ante-
cubital fossa, and nonlesional skin from the volar aspect of
the forearm. AD was diagnosed according to the criteria estab-
lished by Hanifin and Rajka. None of the patients in the study
had been treated with systemic steroids, immunosuppressive
agents, or other drugs which affect immunologic status, for
a period of at least 6 weeks prior to the acquisition of skin
samples. All of the patients in the study exhibited increased
serum IgE levels (range ; 800-3,000 IU). The disease activi-
ty of these patients was considered severe, according to the
grading system developed by Rajka and Langeland (12); the
extent of their skin involvement was approximately 20-30%,
their disease course was continuous in most cases, and all
complained of severe itching. Five age-matched healthy con-
trols (5 males, age range 24-36 yr) were also recruited into the
study, none of whom had any history of atopic disease. 
Portions of each of the skin samples were snap-frozen im-
mediately after the skin biopsy, and were stored at -70℃until
HLA-DR or CD1a staining. The remainders of the skin sam-
ples were further processed for cell culturing.
Immunohistochemical staining for HLA-DR and CD1a
We used CD1a monoclonal antibody in addition to HLA-
DR monoclonal antibody to confirm whether HLA-DR (+)
cells in the epidermis are activated keratinocytes themselves
or Langerhans cells (LCs).
Serial sections, each 6  m thick, were mounted onto silane-
coated slides (Dako, Glostrup, Denmark). Acetone-fixed fro-
zen sections were then stained with HLA-DR monoclonal
antibody (Becton-Dickinson, Los Angeles, CA, U.S.A.) for
1 hr at room temperature. For the staining of the LCs, 4  m
thick sections were incubated with anti CD1a (1:500) (Dako)
at 4℃ for 18 hr. After rinsing in phosphate-buffered saline
(PBS), the sections were visualized with an LSAB kit (Dako),
which utilizes a biotinylated secondary antibody and horse-
radish-streptavidine conjugate. 3-amino-9-ethylcarbazole was
used as a chromogenic substrate. The sections were briefly
counterstained in Mayer’s hematoxylin. Control staining was
performed with normal mouse immunoglobulin, and mani-
fested no immunoreactivity (data not shown). The entire field
of each section was examined at a magnification of ×100, and
the number of HLA-DR (+) cells or CD1a (+) cells per field
(×100) were counted. At least 5 fields of HLA-DR (+) or
CD1a (+) cells in the epidermis were counted.
Keratinocyte culture
Obtained human KCs were isolated as was previously des-
cribed (13). The KCs were cultured in keratinocyte growth
medium (Clonetics, San Diego, CA, U.S.A.), composed of
MCDB 153 medium supplemented with epidermal growth
factor (10 ng/mL), bovine pituitary extract (70  g/mL), hydro-
cortisone (0.5  g/mL), penicillin (100  g/mL), streptomycin
(100  g/mL), and fungizone (0.25  g/mL). Fourth-passage
KCs were used.
MTT assay
Cellular cytotoxicity was assessed via 3-(4, 5-dimethylthi-
azol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay
(14). KCs (1.5×10
4cells/well) were seeded into 96-well plates,
then cultured for 24 hr with various concentrations (0.05, 0.1,
0.2, 0.5, and 1.0  g/mL) of SEA, SEB, and TSST-1. 20  L of
MTT (5 mg/mL Sigma, St. Louis, MO, U.S.A.) was added
to each well, and the cells were incubated for 4 hr at 37℃.
The supernatants were then extracted, and 200  L of dime-
thylsulfoxide was added in order to dissolve the formazan
products. Absorbance was determined spectrophotometrical-
ly at 570 nm, using an ELISA reader. Results were expressed
as a percentage of the control in six cultures. Values are repre-
sented as means±SEM.
Cytokine assay
KCs were cultured in triplicate at a concentration of 4×10
4
cells per well, with 0, 0.1, and 1.0  g of toxin (SEA, SEB,
TSST-1; Sigma) per mL, in 96-well plates. The cell culture
supernatants were collected 48 hr after incubation. The super-
natants of the toxin-treated KCs were analyzed in triplicate
for IL-1 , IL-1 , and TNF- , using a sandwich enzyme-lin-
ked immunosorbent assay (ELISA) kit, which was purchased
from Endogen (Woburn, MA, U.S.A.).
Semi-quantitative RT-PCR for IL-1 and TNF-
The KCs were cultured in triplicate, at a concentration of
4×10
4 cells per well, with 0, 0.1, and 1.0  g of toxin (SEA,
SEB, TSST-1) per mL, in 12-well plates. The cell pellets wereRole of Staphylococcal Superantigen in Atopic Dermatitis 317
collected 6 hr after incubation.
Total RNA was extracted with a TRIzo kit (GibcoBRL Life
Technologies, Inc., Gaithersburg, MD, U.S.A.). 2×10
6 cells
were sedimented via centrifugation (10,000×g, 10 min, 4
℃) and washed twice with ice-cold PBS prior to RNA extrac-
tion. The pellets were then resuspended with 1 mL TRIzol
and 100  L water-saturated chloroform. These mixtures were
then incubated on ice for 15 min, and subsequently spun for
phase separation at 4℃. RNA was precipitated from the upper
aqueous phase via the addition of an equal volume of isopro-
panol. After 60 min of incubation at -20℃,the precipitates
were pelleted by 15 min of centrifugation at 10,000×g at
4℃. Each pellet was washed once with 75% ethanol, and
redissolved in 50  L RNase-free water. 10  L of the RNA
solution was reverse-transcribed into single-strand cDNA
with a reverse transcription system (NEB, MA, U.S.A.), in
a total reaction volume of 20  L using 250 ng oligo (dT)
primer, 7.5 units of avian myeloblastosis virus reverse tran-
scriptase (AMV-RT), and 0.5 U of ribonuclease inhibitor. 
We determined the linear amplification conditions for the
primer pairs used in this study. Identical amounts of cDNA
were subjected to increasing PCR cycle numbers, in order to
delineate the linear amplification range. Increasing amounts
of cDNA (up to 4-fold the starting quantity) were subjected
to PCR at a given cycle number within the linear range, in
order to rule out the possibility that increased amounts of
specific cDNA might result in non-linear PCR amplification.
PCR amplifications of the resulting specific cDNA fragments
were conducted with the following primers: 1) IL-1 (sense,
5′ -GTCTCTGAATCAGAAATCCTTCTATC-3′ and anti-
sense, 5′ -CATGTCAAATTTCACTGCTTCATCC-3′ ) and
2) TNF- (sense, 5′ -TCACCCACACCATCAGGCCGCAT
CG-3′and antisense, 5′ -GGGAAGGTTGGATGATCGT
CCTCC-3′ ). The mixture was incubated for 60 min at 37℃.
Denaturation, annealing, and elongation in the PCR proce-
dure were conducted at 94, 55, and 72℃for 1, 1, and 2 min,
respectively, for 28 cycles for IL-1 , and TNF- , and for 24
cycles for GAPDH (5′ -ATTGTTGCCATCAATGACCC-3′ ,
5′ -AGTAGAGGCAGGGATGATGT-3′ ). 10  L of PCR
products were then separated on 2% agarose gel, and the DNA
fragments were stained with 0.5  g/mL ethidium bromide
and photographed. We quantitated the fragments using a den-
sitometry program (Raytest Isotopenme gerate, Germany).
Statistics
The results are presented as mean values and standard errors.
Significant differences in the HLA-DR and CD1a stainings
of the 3 different skin samples and MTT tests, as well as dif-
ferences in the ELISA and RT-PCR results, were assessed by
Wilcoxon-rank sum tests. A p-value of less than 0.05 was
considered to be statistically significant. All analyses were
conducted using the SPSS software package.
RESULTS
Both HLA-DR and CD1a expression were significantly
elevated in AD skin vs. nonlesional or normal skin
Numbers of HLA-DR (+) cells in the epidermis were sig-
nificantly elevated in the lesional skin samples (53.13±5.29)
as opposed to those from nonlesional skin from AD patients
(25.00±5.10) and from normal skin from the nonatopic con-
trols (38.33±5.95) (p<0.05) (Fig. 1A). Quite similarly, num-
bers of CD1a (+) cells in the epidermis were also significantly
elevated in the lesional skin samples (63.13±3.97) compared
to those from nonlesional skin from AD patients (49.38±
5.37) and from normal skin from the nonatopic controls (46.44
±2.47) (p<0.05) (Fig. 1B). HLA-DR (+) or CD 1a (+) cells
appeared to be located primarily around the basal layer in the
normal controls, and tended to be found scattered through-
out the epidermis in both the lesional and nonlesional skin
samples from the AD patients. However, the numbers of
HLA-DR (+) or CD 1a (+) cells in the nonlesional skin from
the AD patients did not differ significantly from those in the
normal skin acquired from the healthy controls.
SEA, SEB, and TSST-1 significantly augmented IL-1
release from the KCs of lesional skin from AD patients as
opposed to those in the nonlesional skin from the AD
patients, or the normal skin from the nonatopic controls
No significant cellular cytotoxicity was determined to exist
at any of the tested SsAgs concentrations (Fig. 2). A slight
decrease in optical density was detected when 1.0  g/mL of
SEA, SEB, and TSST-1 was added, but this difference was not
statistically significant. Therefore, for the cytokine assay, we
used 0.1 and 1.0  g/mL concentrations, in order to observe
the maximal effects of each SsAg on the KCs.
The detected level of IL-1 released from the cultured KCs
in response to SsAgs exposure was quite low, in a range bet-
ween 3 to 20 pg/mL (Fig. 3). Even in the absence of stimula-
tion, KCs from the lesional skin of the AD patients (atopic
KCs) generated a significant amount of IL-1 , as compared
to the KCs acquired from the nonlesional skin of the AD pa-
tients (atopic control KCs) and the normal skin from the no-
natopic controls (negative control KCs) (p<0.05). Significant
increases in the release of IL-1 from the cultured atopic KCs,
as compared to the atopic control or normal KCs, was only
observed at a concentration of 1.0  g/mL of SEA and SEB,
and 0.1 and 1.0  g/mL of TSST-1 (p<0.05) (Fig. 3). With
regard to TSST-1, a concentration of 1.0  g/mL resulted in
a significant increase in the release of IL-1 from the atopic
KCs, as opposed to the IL-1 release observed at a concentra-
tion of 0.1  g/mL (p<0.05). Also in the case of TSST-1 stim-
ulation, a concentration of 0.1  g/mL resulted in a significant
increase in the release of IL-1 from the atopy control KCs,
as opposed to the IL-1 release observed with no simulation318 K.H. Kim, J.H. Han, J.H. Chung, et al.
N
u
m
b
e
r
 
o
f
 
H
L
A
-
D
R
 
p
o
s
i
t
i
v
e
c
e
l
l
s
/
f
i
e
l
d
 
(
×
1
0
0
)
70
60
50
40
30
20
10
0
Negative control Atopy control Atopy
Fig. 1. (A) Numbers of HLA-DR (+) cells in the epidermis increased significantly in lesional skin, as compared to those from nonlesional skin
from AD patients and from normal skin from nonatopic controls (p<0.05). (B) Numbers of CD1a cells in the epidermis also increased sig-
nificantly quite similarly to those of HLA-DR (+) cells in terms of their increased numbers and their locations in lesional skin, as compared
to those from nonlesional skin from AD patients and from normal skin from nonatopic controls (p<0.05).
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Fig. 2. No significant cellular cytotoxicity was detected with any of
the tested SsAgs concentrations.
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SEA, SEB, and TSST-1 significantly augmented the
release of IL-1 from cultured atopic and atopic control
KCs vs. the negative control KCs
Even in the absence of stimulation, the atopic KCs and
atopic control KCs released significantly greater quantities
of IL-1 as compared to the nonatopic control KCs (p<0.05).
The atopic KCs released a significantly greater amount of IL-
1 in response to SsAgs, as compared to that observed in the
atopic control KCs and negative control KCs (p<0.05). Also,
the atopic control KCs released significantly greater quanti-
ties of IL-1 than did the negative control KCs (p<0.05). Both
concentrations (0.1 and 1.0  g/mL) of SEA, SEB, and TSST-1
resulted in significant increases in IL-1 release from the cul-
tured atopic KCs and the atopic control KCs, as opposed to
that of the negative control KCs (p<0.05) (Fig. 4A-C). The
increased secretion of IL-1 from each KCs proceeded in a
clearly dose-dependent manner. The most pronounced change
was observed, however, with the application of TSST-1. 
In SEA stimulation, both concentrations (0.1 and 1.0  g/
mL) resulted in significant increases in IL-1 release from the
cultured atopy KCs, as opposed to that of the cultured atopy
KCs with no stimulation (p<0.05). In SEB and TSST-1 stim-
ulation, IL-1 release from atopy KCs, atopy control KCs,
and even negative control KCs was significantly greater with
stimulation compared to that without stimulation (p<0.05).
Increased IL-1 mRNA in the atopic KCs and atopic con-
trol KCs vs. the negative control KCs was confirmed by semi-
quantitative RT-PCR, particularly in the cases of SEB and
TSST-1 stimulation (Fig. 4D). Statistically significant differ-
ences among 3 different samples (marked by *) were observed
only in SEB and TSST-1 stimulation.
SEA, SEB, and TSST-1 significantly increased the
release of TNF- from the cultured atopic and atopic
control KCs vs. the negative control KCs
In this study, the most pronounced effects observed involved
the release of TNF- . The atopic KCs released a significant
amount of TNF- in response to SsAgs exposure, as compared
to that observed with the atopic control KCs and the negative
control KCs (p<0.05). Also, the atopic control KCs released
significantly greater amounts of TNF- than did the negative
control KCs (p<0.05). Both tested concentrations (0.1 and
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*1.0  g/mL) of SEA, SEB, and TSST-1 induced significant ele-
vations in the levels of TNF- release in the cultured atopic
KCs and the atopic control KCs, as opposed to that observed
in the negative control KCs (p<0.05) (Fig. 5A-C). The in-
creased TNF- secretion observed in each of the KC types
proceeded in a clearly dose-dependent manner. The most pro-
nounced change in TNF- secretion was also induced by expo-
sure to TSST-1. 
The significantly increased TNF- secretion observed in
atopy KCs, atopy control KCs, and even negative control KCs
with SEA, SEB, and TSST-1 stimulation compared to that
with no stimulation (p<0.05). 
Increased TNF- mRNA in the atopic KCs vs. the atopic
control KCs and negative control KCs was revealed by the
results of semi-quantitative RT-PCR, particularly in the cases
of 1.0  g/mL of SEA and SEB stimulation (Fig. 5D). 
DISCUSSION
Keratinocytes are the most abundant cell type in the epider-
mis by far, and our perception of the role of KCs in inflamma-
tion has changed significantly. Whereas at one time, the KCs
were believed to be passive target, they are now considered
active participants. Keratinocytes exhibit the ability to gen-
erate and release a host of lipid and protein cytokines. Among
the protein-derived cytokines which are generated by ker-
atinocytes, TNF- , and IL-1 have been termed primary cyto-
kines (15). Therefore, we opted to focus our study on these
cytokines, with regard to the role played by SsAgs in AD. 
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� comparison among doses of toxins.Travers et al. (11) reported that HLA-DR expression in
the KCs exacerbates inflammatory skin responses to SsAgs.
This conclusion was reached by virtue of the observation that
significantly higher HLA-DR expression occurred in KCs
from psoriatics after patch testing with SsAgs. This demon-
strates that smaller amounts of SsAgs are required to trigger
inflammation in AD patients in vivo, when the KCs express
HLA-DRSsAgs can also bind to and activate MHC class II
on nonprofessional antigen processing cells such as KCs, as
the result of cytokine stimulation. However in this study, we
found that both HLA-DR (+) cells or CD1a (+) cells in the
epidermis were significantly more abundant in lesional skin
from AD patients only than in nonlesional skin from AD
patients and normal skin from nonatopic controls. Our study
suggests that HLA-DR (+) cells correspond to Langerhans’
cells because increased numbers and the locations of immuno-
positive cells showed quite similar pattern in the epidermis
of each sample. Actually IgE-bearing Langerhans’ cells are
reported to be increased in AD skin (16).
Girolomoni and Pastore (9) reported that GM-CSF was
overexpressed in the KCs located in AD lesions, and also re-
ported that even the KCs which were cultured from the non-
lesional skin of AD patients generated higher levels of GM-
CSF, both basally and in response to IL-1 or phorbol esters,
than did the KCs isolated from nonatopic subjects. Thus, they
suggested that dysregulated cytokine production in KCs
might be a principal contributor to the pathophysiology of
AD (10, 17). 
Ezepchuk et al. (6) reported that S. aureus isolates obtained
from the skin of AD patients exhibited characteristic super-
antigenic toxins, and stimulated TNF- secretion from a Ha-
Cat cell line. In their HaCat cell experiment, TNF- expres-
Role of Staphylococcal Superantigen in Atopic Dermatitis 321
T
N
F
-
a
l
p
h
a
 
(
p
g
/
m
L
)
80
70
60
50
40
30
20
10
0
0 0.1 1
Negative control
Atopy control
Atopy
Negative control
Atopy control
Atopy
Negative control
Atopy control
Atopy
SEA ( g/mL)
T
N
F
-
a
l
p
h
a
 
(
p
g
/
m
L
)
350
300
250
200
150
100
50
0
0 0.1 1
TSST-1 ( g/mL)
T
N
F
-
a
l
p
h
a
 
(
p
g
/
m
L
)
100
90
80
70
60
50
40
30
20
10
0
0 0.1 1
SEB ( g/mL)
A
C
B
*,� p<0.05 *,� p<0.05
*,� p<0.05
*
*
*
*
*
� �
*
*
�
*,�
*,�
*,� *,�
*,�
*,�
*,�
*,�
*,�
*,�
*,�
Negative control
Atopy control
Atopy
Negative control
Atopy control
Atopy
%
 
o
f
 
n
e
g
a
t
i
v
e
 
c
o
n
t
r
o
l
 
(
0
 
g
/
m
L
)
500
450
400
350
300
250
200
150
100
50
0
D
*,� p<0.05
*
* *
*
0 0.1 1.0 0.1 1.0 0.1 1.0
SEA SEB TSST-1
0 0.1 1 0.1 1 0.1 1
SEA SEB TSST-1
�
�
�
*,�
Fig. 5. TNF- release levels from the cultured KCs and TNF- mRNA in response to SsAgs. Both tested concentrations (0.1 and 1.0  g/mL)
of SEA, SEB, and TSST-1 resulted in significant increases in the release of TNF- from cultured atopic KCs and atopic control KCs vs. the
negative control KCs (p<0.05). Increased TNF- mRNA in the atopic KCs vs. the atopic control KCs and negative control KCs was observed,
particularly in the cases of 1.0  g/mLof SEA and SEB stimulations. (A) TNF- release in response to SEA, (B) TNF- release in response
to SEB, (C) TNF- release in response to TSST-1, (D) TNF- mRNA levels measured by semi-quantitative RT-PCR. *comparison among
skin samples, 
� comparison among doses of toxins.sion levels after simulation with SEA, SEB, and TSST-1 were
vanishingly low, ranging from about 5 to 15 pg/mL, but were
still significantly higher than those measured in PBS controls.
It was reported that, in organ-cultured human skin, SsAgs
could induce cytokines (TNF- , IL-1 , and IL-1 ) and that,
among these cytokines, TNF- was the most abundantly ex-
pressed in the KCs, at both the protein and mRNA levels,
whereas IL-1 and IL-1 were demonstrated only at the mR-
NA level (7). These studies suggested that SsAgs can induce
a variety of cytokines in the KCs, and may perform a vital
function in the induction of AD. However, there have not
yet been any studies which have compared changes in the lev-
els of TNF- , IL-1 , and IL-1 in response to SsAgs exposure
in the lesional skin of AD patients, as compared to those occur-
ring in the nonlesional skin of AD patients or in normal skin.
In this study, we compared the reactivity of 3 different sam-
ples of human skin to SsAgs. These samples were obtained
from lesions in AD patients, normal-looking skin in AD pa-
tients, and normal skin. We determined that cultured KCs,
particularly those obtained from the AD lesions, released
slightly higher quantities of IL-1 , IL-1 and TNF- than
did KCs in the absence of staphylococcal antigenic stimula-
tion, as was expected. When SsAgs were added to the cul-
tures, we noted that IL-1 , IL-1 and TNF- were gener-
ated and released in significantly greater quantities in the
KCs cultured from AD lesions than in those of the normal
looking skin from AD patients or from the KCs of normal
skin. With regard to IL-1 , both basal and post-SsAgs-stim-
ulated levels were quite low. However, exposure to SsAgs
resulted in significantly elevated levels of IL-1 release in
the KCs cultured from the AD lesions than in those cultured
from normal looking skin or from normal skin. With regard
to IL-1 , both basal and post-SsAgs-stimulated levels were
still quite low. However, exposure to SsAgs resulted in sig-
nificant increases in the amount of IL-1 released from the
KCs, which were cultured from the AD lesions and the nor-
mal looking skin of AD patients, as opposed to the KCs iso-
lated from normal skin. The most pronounced responses were
observed in the case of TNF- . SsAgs exposure resulted in
significant increases in the release of TNF- from the KCs,
which were cultured from the AD lesions and the normal
looking skin, as opposed to the KCs isolated from normal
skin. Furthermore, SsAgs exposure significantly augmented
IL-1 and TNF- release from the KCs cultured from the
AD lesions, as compared to those cultured from normal-look-
ing AD skin. These exaggerated IL-1 and TNF- responses
to SsAgs were also corroborated by the results of semi-quan-
titative RT-PCR, which measured mRNA levels. 
All in all, our study demonstrated that KCs cultured from
the affected skin of AD patients generate greater quantities
of inflammatory cytokines in response to SsAgs exposure than
do the KCs of nonlesional skin or normal skin. This may be
attributable to intrinsic defect or altered responsiveness in
the AD lesional KCs. This, then may constitute one of the
pathomechanisms by which S. aureus induces and aggravates
skin lesions in cases of AD.
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